Business Description
Dr. Martens PLC
ISIN : GB00BL6NGV24
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.21 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1.34 | |||||
Debt-to-EBITDA | 3.19 | |||||
Interest Coverage | 2.36 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.98 | |||||
Beneish M-Score | -3.27 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.8 | |||||
3-Year EBITDA Growth Rate | 11.6 | |||||
3-Year EPS without NRI Growth Rate | -15.3 | |||||
3-Year Book Growth Rate | 36.7 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.26 | |||||
Quick Ratio | 0.99 | |||||
Cash Ratio | 0.49 | |||||
Days Inventory | 356.59 | |||||
Days Sales Outstanding | 40.11 | |||||
Days Payable | 127.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.79 | |||||
3-Year Average Share Buyback Ratio | 1.3 | |||||
Shareholder Yield % | 12.1 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 65.52 | |||||
Operating Margin % | 8.81 | |||||
Net Margin % | 3.65 | |||||
FCF Margin % | 23.84 | |||||
ROE % | 8.27 | |||||
ROA % | 3.03 | |||||
ROIC % | 6.98 | |||||
ROC (Joel Greenblatt) % | 14.41 | |||||
ROCE % | 8.7 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.66 | |||||
Forward PE Ratio | 20.86 | |||||
PE Ratio without NRI | 18.82 | |||||
Price-to-Owner-Earnings | 5.38 | |||||
PEG Ratio | 0.96 | |||||
PS Ratio | 0.85 | |||||
PB Ratio | 2.05 | |||||
Price-to-Tangible-Book | 11.9 | |||||
Price-to-Free-Cash-Flow | 3.39 | |||||
Price-to-Operating-Cash-Flow | 3.06 | |||||
EV-to-EBIT | 15.55 | |||||
EV-to-Forward-EBIT | 8.37 | |||||
EV-to-EBITDA | 7.56 | |||||
EV-to-Forward-EBITDA | 6.57 | |||||
EV-to-Revenue | 1.32 | |||||
EV-to-Forward-Revenue | 1.57 | |||||
EV-to-FCF | 5.12 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.52 | |||||
Price-to-Graham-Number | 3.11 | |||||
Earnings Yield (Greenblatt) % | 6.43 | |||||
FCF Yield % | 28.65 | |||||
Forward Rate of Return (Yacktman) % | 33.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Dr. Martens PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 18,669.449 | ||
EPS (TTM) (MXN) | 0.517 | ||
Beta | 0.24 | ||
Volatility % | 1.35 | ||
14-Day RSI | 0 | ||
14-Day ATR (MXN) | 0 | ||
20-Day SMA (MXN) | 29.87 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (MXN) | 29.87 - 29.87 | ||
Shares Outstanding (Mil) | 962.59 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Dr. Martens PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Dr. Martens PLC Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Dr. Martens PLC Frequently Asked Questions
What is Dr. Martens PLC(MEX:DOCS)'s stock price today?
When is next earnings date of Dr. Martens PLC(MEX:DOCS)?
Does Dr. Martens PLC(MEX:DOCS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |